
Quest Diagnostics announced a quarterly cash dividend of $0.86 per share, to be paid on October 21, 2026, to shareholders recorded by October 6, 2026. This dividend reflects the company's ongoing commitment to returning value to shareholders. Quest Diagnostics is a major player in diagnostic services, serving many U.S. physicians and hospitals with laboratory insights that improve healthcare outcomes.